| SBI Magnum Sector Umbrella - Pharma Fund - Dividend |
| Objective |
| The scheme aims to provide the
investors maximum growth opportunity through equity investment
in stocks of Pharma Sector. |
| Scheme Performance (%) as on
Mar 22 , 2007 |
| 14 days |
1 month |
3 months |
1 year |
3 yrs* |
Inception* |
| 2.72 |
-4.87 |
-4.37 |
-4.47 |
34.86 |
16.36 | |
| Top 10 Holdings as on
Feb 28, 2007 |
| Company |
Nature |
Value (Cr.) |
% |
| Dishman
Pharmaceuticals & Chemicals |
EQ |
8.05 |
16.3 |
| Vimta Labs Ltd |
EQ |
5.45 |
11.03 |
| Glaxo Smithkline
Pharmaceuticals Ltd |
EQ |
5.07 |
10.26 |
| Cipla Ltd |
EQ |
4.72 |
9.56 |
| Orchid Chemicals
& Pharmaceuticals Ltd |
EQ |
4.39 |
8.89 |
| Aventis Pharma
India Ltd. |
EQ |
3.85 |
7.79 |
| Indoco Remedies
Ltd. |
EQ |
3.48 |
7.04 |
| Pfizer Ltd |
EQ |
2.93 |
5.94 |
| Wockhardt
Limited |
EQ |
2.86 |
5.79 |
| Ranbaxy
Laboratories Ltd |
EQ |
2.79 |
5.65 | |
| Mutual Fund |
| SBI Mutual Fund |
| 191, Maker Tower |
| E, Cuffe Parade |
| Mumbai |
| Tel.-22180221,, |
| Asset Management Company |
| SBI Funds Management
Ltd. |
| 191, Maker Tower E Wing,
|
| Cuffe Parade |
| Mumbai - 400005 |
| Tel.- 22180221,22180225 |
| Registrar |
| NA
| *Returns are annualized |
| |
|
| Email Address |
partnerforlife@sbimf.com |
| Net Asset Value
(Rs/Unit) |
27.15 |
As On Mar 22, 2007 |
Fund Information
| Type of Scheme |
Open Ended |
| Nature of
Scheme |
Equity |
| Inception Date |
Mar 7,
1999 |
| Face
Value(Rs/Unit) |
10 |
| Fund Size (Rs. in
crores) |
49.39 on Feb 28, 2007 |
| Increase/Decrease since
Jan 31, 2007 (Rs. in crores) |
-5.84 |
| Minimum
Investment (Rs) |
2000 |
| Purchase
Redemptions |
Daily |
| NAV
Calculation |
Daily |
| Entry Load |
Amount Bet. 0 to
49999999 then Entry load is 2.25%. and Amount greater
than 50000000 then Entry load is 0%. |
| Exit Load |
If redeemed bet.
0 Months to 6 Months; and Amount Bet. 0 to 49999999 then
Exit load is 1%. and Amount greater than 50000000 then
Exit load is 0%. | |
| Last Dividend Declared |
| 39 % |
On Jan 3,
2005 |
| Top Industry Allocation
as on Feb 28, 2007 |
| Pharmaceuticals |
96.33% |
| Diversified |
2.42% |
| Asset Allocation as on
Feb 28, 2007 |
| Equity |
Debt |
Money
Market |
| 98.74 |
0 |
1.26 | | |